Wells Fargo lowered the firm’s price target on Centene (CNC) to $35 from $41 and keeps an Equal Weight rating on the shares. The firm notes results in Q3 were better than it feared and Centene increased EPS guidance modestly. However, the outlook for enhanced subsidy extension has weighed on the stock as visibility to earrings recovery worsens, Wells adds.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- OSCR, ELV, CNC: Health Insurer Stocks on Watch as Trump Pushes ACA Funds Directly to Americans
- Centene to Present at UBS 2025 Healthcare Conference
- Centene backs FY25 adjusted EPS view ‘at least’ $2.00, consensus $1.96
- Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
- Trump Trade: Trump says ‘enrichment’ of health insurers ‘must stop’